Gabapentinoids: Difference between revisions
>Azed m Added a citation |
>Azed m Added two cites. Changed wording. |
||
Line 2: | Line 2: | ||
[[File:Gabapentinoidsstructure.png|250px|thumbnail|Diagram showing the structural similarities of [[GABA|gamma-aminobutyric acid]] (GABA), [[pregabalin]] and [[gabapentin]].]] | [[File:Gabapentinoidsstructure.png|250px|thumbnail|Diagram showing the structural similarities of [[GABA|gamma-aminobutyric acid]] (GABA), [[pregabalin]] and [[gabapentin]].]] | ||
'''Gabapentinoids''' are a chemical class of [[psychoactive substances]] derived from [[GABA|gamma-aminobutyric acid]] (GABA). | '''Gabapentinoids''' are a chemical class of [[psychoactive substances]] derived from [[GABA|gamma-aminobutyric acid]] (GABA).{{citation needed}} Members of this class include [[gabapentin]], [[F-phenibut]], [[phenibut]] and [[pregabalin]]. | ||
Gabapentinoids are commonly prescribed for epilepsy, neuropathic pain, and [[restless legs syndrome]]. [[Subjective effects]] include [[sedation]], [[muscle relaxation]], and [[anxiety suppression]]. | Gabapentinoids are commonly prescribed for epilepsy, neuropathic pain, and [[restless legs syndrome]]. [[Subjective effects]] include [[sedation]], [[muscle relaxation]], and [[anxiety suppression]]. | ||
Line 12: | Line 12: | ||
==Pharmacology== | ==Pharmacology== | ||
Gabapentinoids act by | Gabapentinoids act by inhibiting the α2δ subunit-containing voltage-dependent calcium [[receptor#Ion_channels|channels]] (VGCCs).<ref>Patel, R., & Dickenson, A. H. (2016). Mechanisms of the gabapentinoids and α2δ‐1 calcium channel subunit in neuropathic pain. Pharmacology research & perspectives, 4(2).https://doi.org/10.1002/prp2.205</ref> While all gabapentinoids block the α2δ channels, they also have unique pharmacological characteristics such as enzyme inhibition.<ref>Goldlust, A., Su, T. Z., Welty, D. F., Taylor, C. P., & Oxender, D. L. (1995). Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy research, 22(1), 1-11.https://doi.org/10.1016/0920-1211(95)00028-9</ref> | ||
==Examples== | ==Examples== | ||
*[[F-Phenibut]] | *[[F-Phenibut]] | ||
*[[Gabapentin]] | *[[Gabapentin]] | ||
Line 22: | Line 21: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Depressants]] | *[[Depressants]] | ||
Line 30: | Line 28: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/Gabapentinoid Gabapentinoid (Wikipedia)] | *[https://en.wikipedia.org/wiki/Gabapentinoid Gabapentinoid (Wikipedia)] | ||
Line 38: | Line 35: | ||
[[Category:Chemical class]] | [[Category:Chemical class]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||